Intuitive Surgical Q1 2026 Results Show Strong Growth.

Intuitive Surgical Q1 2026 Results Show Strong Growth. Intuitive Surgical reported solid first quarter performance in 2026, demonstrating continued strength in its robotic surgery platform business. The company's da Vinci surgical system remains the dominant player in minimally invasive robotic surgery, with expanding adoption across multiple surgical specialties worldwide. Revenue growth reflected both increased procedure volumes and higher average selling prices for system installations. The company continues to benefit from favorable demographic trends, including an aging global population requiring surgical interventions. Management highlighted strong international expansion opportunities, particularly in Europe and Asia-Pacific regions where robotic surgery adoption is accelerating. Procedure volumes showed healthy growth momentum, indicating robust demand from hospital customers.